SYMPOSIUM: Advances in Preclinical Models for Cancer Immunotherapy

November 9, 2018 - Sanofi Gentilly Val-de-Bièvre


Sanofi Gentilly Val-de-BièvreCrown Bioscience and Sanofi cordially invite you to a jointly organised symposium on the latest advances in preclinical models for developing cancer immunotherapies, on November 9th.

Internationally renowned speakers from academia and industry will discuss the latest advancements in in vivo models, for efficiently progressing oncology and immuno-oncology agent drug development programmes.

The symposium will be held on the Sanofi site in Gentilly, France on November 9th, 2018. Attendance is free of charge, on a first come first serve basis, with registration for the event mandatory.

Presentation & Speakers

Sukhvinder Sidhu

Global Head of Pharmacology, Sanofi Oncology
Opening Remarks

Jean-Pierre Wery

CEO, Crown Bioscience
Opening Remarks

James Harper

Senior Scientist, MedImmune
Selecting Preclinical Models for Immunotherapy

Donald Drake

Senior Director, VaxDesign Campus, Sanofi Pasteur
Use of an In Vitro Human Immune Platform to Support the Development of Cancer Immunotherapies

Xavier Montagutelli

Research Director, Institut Pasteur; Head, Mouse Genetics Laboratory
Why Host Genetics Matter: Examples from Infectious Diseases and Vaccination

Frédéric Tangy

Director of Research DR1, CNRS; Head of the Viral Genomics and Vaccination Unit, Institut Pasteur
Vaccination and Immunotherapy, the Need for the Right Animal Model

Eliane Piaggio

Head of Translational Immunotherapy, Institut Curie
Humanised Mice Models for the Study of Cancer Immunotherapy

Michael Seiler

Vice President, Commercial Products, Taconic
Humanised Immune System Models: Novel Models for Novel Immunotherapies

Sandra Li

Team Leader, Exploratory Pharmacology R&D Group, Ablynx
Syngeneic Tumour Models: Translational and Predictive Value in Preclinical Immuno-Oncology Research

Dominique Tierny

CEO and Founder, Oncovet Clinical Research
The Companion Dog as a Missing Link in Anticancer Drug Development for Humans

Davy Ouyang

Senior Director, Translational Oncology, Crown Bioscience
Animal Modelling for Immuno-Oncology Drug Discovery

Attendance for the symposium is free, however registration for the event is mandatory.

Register Now

Register Now

Your privacy is important to us.
We'll never share your information.

SHARE THIS